Skip to content
Articaine
Orabloc, Septocaine (articaine) is a small molecule pharmaceutical. Articaine was first approved as Septocaine on 2000-04-03. It is used to treat pain in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Combinations
Orabloc, Septocaine (discontinued: Ultacan)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Articaine hydrochloride
+
Epinephrine bitartrate
Tradename
Company
Number
Date
Products
SEPTOCAINEDeprocoN-020971 RX2000-04-03
2 products, RLD, RS
ORABLOCPierrelN-022466 RX2010-02-26
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
articaine hydrochloride and epinephrineNew Drug Application2022-12-12
orablocNew Drug Application2018-11-22
septocaine and epinephrineNew Drug Application2020-03-18
ultacan ultacan forteANDA2017-07-20
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
painEFO_0003843D010146R52
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N01: Anesthetics
— N01B: Local anesthetics
— N01BB: Amide local anesthetics
— N01BB08: Articaine
— N01BB58: Articaine, combinations
HCPCS
No data
Clinical
Clinical Trials
164 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalariaD008288EFO_0001068B5498234521101
Falciparum malariaD016778EFO_0007444B502111621649
Hiv infectionsD015658EFO_0000764B202—15—8
Vivax malariaD016780EFO_0007445B511—24—7
HivD006678O98.72——1—3
AnemiaD000740EFO_0004272D64.9———2—2
Drug interactionsD004347———1—1
TuberculosisD014376EFO_0000774A15-A19———1—1
SchistosomiasisD012552EFO_1001475B65———1—1
HelminthiasisD006373EFO_1001342B65-B83———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382U07.1——1——1
FeverD005334HP_0001945R50.9——1——1
Asymptomatic diseasesD058070—11——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—31———3
PharmacokineticsD01059921———2
Schistosomiasis haematobiaD012553EFO_0007530B65.0—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Parasitic diseasesD010272EFO_0001067B881————1
ParasitemiaD0185121————1
Protozoan infectionsD011528B50-B641————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PneumoniaD011014EFO_0003106J18————22
Drug resistanceD004351Z16.30————11
MalnutritionD044342EFO_0008572E40-E46————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameARTICAINE
INNarticaine
Description
4-methyl-3-[[1-oxo-2-(propylamino)propyl]amino]-2-thiophenecarboxylic acid methyl ester is a thiophenecarboxylic acid.
Classification
Small molecule
Drug classlocal anesthetics
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC
Identifiers
PDB—
CAS-ID23964-58-1
RxCUI592464
ChEMBL IDCHEMBL1093
ChEBI ID—
PubChem CID32170
DrugBankDB09009
UNII IDD3SQ406G9X (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,685 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
318 adverse events reported
View more details